eCardio Diagnostics, Inc. Series B $10M*

Posted in I - Series B, Q - 3Q09, R - SOUTH WEST, X - Device (Cardiology), XX - TX

eCardio Diagnostics (The Woodlands, TX) a X-stage company focused on the diagnosis, monitoring and clinical management of cardiac arrhythmias, closed a $10M Series B financing.* Participants include Sequoia Capital.
*This statement estimates undisclosed financial information

SynCardia Systems, Inc.: Series D $10.3M

Posted in I - Series D, Q - 2Q09, R - SOUTH WEST, X - Device (Cardiology), XX - AZ

SynCardia Systems (Tuscan, AZ) commercial-stage manufacturer of the temporary cardiowest total artificial heart, closed a $10.3M Series D financing. Participants include Highway 12 Ventures.

Savara Pharmaceuticals, Inc.: Series A $1.0M

Posted in I - Series A, Q - 2Q09, R - SOUTH WEST, X - Device (Delivery), XX - TX

Savara Pharmaceuticals (Austin, TX) a preclinical-stage developer of dry powder and nebulized-based therapeutic inhalation drug delivery platform, closed a $1.0M Series A financing. Participants were not identified.

Glycos Biotechnologies, Inc.: Series A $5M

Posted in I - Series A, Q - 2Q09, R - SOUTH WEST, X - Biofuel, XX - TX

Glycos Biotechnologies (Houston, TX) a development-stage biofuels company focused on production of intermediate chemicals for biodegradable, non-degradable plastics, surfactants and fuels, closed a $5M Series A financing. Participants include Draper Fisher Jurvetson and DFJ Mercury.

Molecular Templates, Inc.: Series A $2.5M

Posted in I - Series A, Q - 2Q09, R - SOUTH WEST, X - Oncology, X - Therapeutic Platform, XX - TX

Molecular Templates (Austin, TX) a preclinical-stage company focused on a protein platform for the development of melanoma and other oncology therapeutics, closed a $2.5M Series A financing. Participants include Santé Ventures.

Orthoscan, Inc.: Series B $7.5M

Posted in I - Series B, Q - 4Q08, R - SOUTH WEST, X - Imaging, X - Orthopedic

Orthoscan (Scottsdale, AZ) developer of medical device imaging products with a focus on orthopaedics, closed a $7.5M Series B financing. Participants include River Cities Capital Funds, Aphelion Capital and California Technology Ventures.

TelaDoc Medical Services, Inc.: Series A $3M

Posted in I - Series A, Q - 2Q08, R - SOUTH WEST, X - TeleMedicine

TelaDoc Medical Services (Dallas, TX) a commercial stage company focused on providing around-the-clock access to telephone consults with primary care doctors who diagnose medical problems and prescribe medication, closed a $3M Series A financing. Participants include Trident Capital.

NanoMR, Inc.: Series A $5.5M

Posted in I - Series A, Q - 2Q08, R - SOUTH WEST, X - Device (Diagnostic)

NanoMR (Albuquerque, NM) early-stage blood diagnostics device startup focused on real time, ultrasensitive detection of samples, closed a $5.5M Series A financing. Participants include vSpring Capital, Dow Venture Capital and Sun Mountain Capital.

Medipacs, Inc.: Series A $1.7M

Posted in I - Series A, Q - 2Q08, R - SOUTH WEST, X - Device (Delivery), X - Diabetes, X - Pain

Medipacs (Tucson, AZ) early-stage drug infusion device company using hydrogel polymers to regulate distribution of medicine, closed a $1.7M Series A financing. Participants included Mesa Verde Venture Partners.

Cayenne Medical, Inc.: Series C $15M

Posted in I - Series C, Q - 1Q08, R - SOUTH WEST, X - Orthopedic

Cayenne Medical (Scottsdale, AZ) developer of soft tissue reconstruction and repair segment for orthopedic applications, closed a $15M Series C financing. Participants include Investor Growth Capital and Split Rock Partners.

« Previous Entries Next Entries »

to top of page...